Fig. 3From: The comparative study for survival outcome of locally advanced cervical cancer treated by neoadjuvant arterial interventional chemotherapy or intravenous chemotherapy followed by surgery or concurrent chemoradiationThree-year survival curves (eliminate patients with lymph node metastases). A 3-year PFS of all patients in different subgroups (p = 0.626). B 3-year OS of all patients in different subgroups (p = 0.64). OS, overall survival; PFS, progression-free survivalBack to article page